Penumbra, Inc. announced 90-day results of the STORM-PE randomized controlled trial (RCT) that is evaluating computer-assisted va ...
Penumbra (NYSE:PEN) today announced 90-day results from the landmark STORM-PE randomized trial of its thrombectomy technology ...
SPECT lung scans show low clot risk at three months, suggesting a potential alternative to CT in pulmonary embolism diagnosis ...
Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...
Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...
Despite advances in diagnosis and treatment, PE continues to place a significant burden on patients and health systems worldwide; at least 400,000 hospitalizations in the US are annually as a result ...
In these guidelines, the American Heart Association provides updated guidance for resuscitation of adults and children in cardiac arrest or with a life-threatening condition due to special ...
Abstract: Manual analysis and diagnosis of COVID-19 through the examination of Computed Tomography (CT) images of the lungs can be time-consuming and result in errors, especially given high volume of ...
The EKOS acoustic pulse thrombolysis treatment. [Image courtesy of Boston Scientific] Boston Scientific (NYSE:BSX) announced positive data from a randomized clinical trial evaluating its EKOS ...
Abstract: Perfusion SPECT is a medical imaging modality often used alongside other techniques to diagnose pulmonary embolism. In this article, we developed a method that enables the calculation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results